Acorda Therapeutics Inc., of Ardsley, N.Y., beat analyst estimates for the third quarter, posting GAAP net income of $9.6 million, or 24 cents per share, well above consensus estimates of 10 cents per share.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST